Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates

Chu, Wan-Yu; Annink, Kim V.; Nijstad, A. Laura; Maiwald, Christian A.; Schroth, Michael; el Bakkali, Loubna; van Bel, Frank; Benders, Manon J. N. L.; van Weissenbruch, Mirjam M.; Hagen, Anja; Franz, Axel R.; Dorlo, Thomas P. C.; Allegaert, Karel; Huitema, Alwin D. R.

dc.contributor.author	Maiwald, Christian Achim
dc.contributor.author	Franz, Axel Rainer
dc.date.accessioned	2023-04-27T08:54:14Z
dc.date.available	2023-04-27T08:54:14Z
dc.date.issued	2022
dc.identifier.issn	0312-5963
dc.identifier.uri	http://hdl.handle.net/10900/139757
dc.language.iso	en	de_DE
dc.publisher	Adis Int Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s40262-021-01068-0	de_DE
dc.subject.ddc	610	de_DE
dc.title	Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_02977
utue.publikation.seiten	321-333	de_DE
utue.personen.roh	Chu, Wan-Yu
utue.personen.roh	Annink, Kim V.
utue.personen.roh	Nijstad, A. Laura
utue.personen.roh	Maiwald, Christian A.
utue.personen.roh	Schroth, Michael
utue.personen.roh	el Bakkali, Loubna
utue.personen.roh	van Bel, Frank
utue.personen.roh	Benders, Manon J. N. L.
utue.personen.roh	van Weissenbruch, Mirjam M.
utue.personen.roh	Hagen, Anja
utue.personen.roh	Franz, Axel R.
utue.personen.roh	Dorlo, Thomas P. C.
utue.personen.roh	Allegaert, Karel
utue.personen.roh	Huitema, Alwin D. R.
dcterms.isPartOf.ZSTitelID	Clinical Pharmacokinetics	de_DE
dcterms.isPartOf.ZS-Issue	2	de_DE
dcterms.isPartOf.ZS-Volume	61	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE